drugset / Trial / NCT05533372
MAD Study of IA-14069
RandomizedSequentialTriple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ascending oral doses of IA-14069 in healthy subjects and in patients with RA on stable dosese of MTX, with preliminary assessment of efficacy in RA patients.
Timeline
- Start
- 2022-10-10
- Primary completion
- 2025-11
- Completion
- 2026-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IA-14069 | Unknown | — | Oral |
| Subject | Methotrexate | Small molecule | — | Oral |